Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Dollar change -0.03
Percentage change -0.93	%

Peers: ILMN PACB TWST NTLA CRSP EXAS CDNA GH FATE TXG

| Held by: VTI IWM VXF IWO VTWO VHT IWC VTWG RSSL UWM

Index	RUT	P/E	-	EPS (ttm)	-1.23	Insider Own	58.55%	Shs Outstand	49.12M	Perf Week	3.24%
Market Cap	157.91M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	-0.05%	Shs Float	20.52M	Perf Month	-0.31%
Income	-60.35M	PEG	-	EPS next Q	-0.20	Inst Own	24.47%	Short Float	7.81%	Perf Quarter	49.77%
Sales	93.22M	P/S	1.69	EPS this Y	28.50%	Inst Trans	-7.40%	Short Ratio	12.14	Perf Half Y	10.00%
Book/sh	0.45	P/B	7.09	EPS next Y	46.57%	ROA	-36.29%	Short Interest	1.60M	Perf Year	-20.45%
Cash/sh	0.91	P/C	3.49	EPS next 5Y	-	ROE	-128.20%	52W Range	1.88 - 6.31	Perf YTD	-34.63%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-37.60%	ROI	-58.24%	52W High	-49.45%	Beta	1.40
Dividend TTM	-	Quick Ratio	1.98	Sales past 5Y	23.82%	Gross Margin	53.01%	52W Low	69.68%	ATR (14)	0.19
Dividend Ex-Date	-	Current Ratio	2.73	EPS Y/Y TTM	37.72%	Oper. Margin	-51.65%	RSI (14)	57.81	Volatility	4.61% 6.15%
Employees	330	Debt/Eq	3.81	Sales Y/Y TTM	9.66%	Profit Margin	-64.74%	Recom	2.00	Target Price	4.80
Option/Short	Yes / Yes	LT Debt/Eq	3.66	EPS Q/Q	48.02%	Payout	-	Rel Volume	0.72	Prev Close	3.22
Sales Surprise	-1.13%	EPS Surprise	-1.35%	Sales Q/Q	-1.52%	Earnings	Nov 14 AMC	Avg Volume	131.98K	Price	3.19
SMA20	6.84%	SMA50	11.02%	SMA200	-5.21%	Trades		Volume	94,530	Change	-0.93%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-06-24	Downgrade	JP Morgan	Overweight → Neutral
Aug-06-24	Downgrade	BTIG Research	Buy → Neutral
Jun-21-24	Initiated	Craig Hallum	Buy	$7.50
Dec-14-23	Initiated	Guggenheim	Neutral
Jul-05-23	Resumed	JP Morgan	Overweight	$18
Feb-02-23	Initiated	UBS	Buy	$14
Nov-03-22	Initiated	CapitalOne	Overweight	$19
Oct-06-22	Initiated	Stephens	Overweight	$16
Jun-22-22	Initiated	BTIG Research	Buy	$16
Jan-06-22	Resumed	Piper Sandler	Overweight	$23
May-11-21	Initiated	Piper Sandler	Overweight	$28
May-11-21	Initiated	Morgan Stanley	Overweight	$26
May-11-21	Initiated	JP Morgan	Overweight	$23
May-11-21	Initiated	Canaccord Genuity	Buy	$25

Show Previous Ratings

Nov-05-24 08:00AM	Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode Discovery IO60 and Mouse FFPE IO Panel (GlobeNewswire) +17.94%
Oct-28-24 08:30AM	Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024 (GlobeNewswire)
Oct-07-24 08:00AM	Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy (GlobeNewswire) +15.47%
Oct-03-24 04:00PM	Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors (GlobeNewswire) +8.81%
Aug-05-24 08:59PM	AKYA Stock Earnings: Akoya Biosciences Meets EPS, Misses Revenue for Q2 2024 (InvestorPlace) -6.51%
05:10PM	Loading…
05:10PM	Akoya Biosciences (AKYA) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:07PM	Akoya: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Akoya Biosciences Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-15-24 04:00PM	Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences (GlobeNewswire) +13.30%
May-15-24 08:02AM	Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating (MT Newswires)
May-14-24 01:55PM	Top Midday Decliners (MT Newswires) -29.61%
09:01AM	Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
08:14AM	Top Premarket Decliners (MT Newswires)
07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-13-24 08:54PM	AKYA Stock Earnings: Akoya Biosciences Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:35PM	Loading…
05:35PM	Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:36PM	Akoya: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Akoya Biosciences Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-09-24 08:00AM	Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients (GlobeNewswire) +9.00%
May-06-24 10:00AM	Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
08:00AM	Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts (GlobeNewswire)
May-02-24 08:00AM	Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows (GlobeNewswire)
Apr-22-24 04:05PM	Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024 (GlobeNewswire)
Apr-05-24 08:00AM	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale (GlobeNewswire)
Mar-05-24 09:52AM	Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.72%
07:00AM	Q4 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-04-24 08:51PM	AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
05:31PM	Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook (GuruFocus.com)
05:15PM	Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:21PM	Akoya: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook (GlobeNewswire)
Feb-08-24 04:05PM	Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference (GlobeNewswire)
Feb-07-24 04:13AM	Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength? (Zacks)
Jan-18-24 08:00AM	Akoya Biosciences' Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases (GlobeNewswire)
Jan-10-24 08:00AM	Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board (GlobeNewswire)
Jan-08-24 01:07AM	Akoya Biosciences Issues Preliminary Revenue Results; Issues 2024 Guidance (RTT News) +20.09%
Jan-07-24 08:00AM	Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform (GlobeNewswire)
08:00AM	Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook (GlobeNewswire)
08:00AM	Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow (GlobeNewswire)
Jan-05-24 08:34AM	How Akoya Biosciences (AKYA) Stock Stands Out in a Strong Industry (Zacks)
Dec-27-23 09:55AM	How Much Upside is Left in Akoya (AKYA)? Wall Street Analysts Think 86% (Zacks)
Dec-20-23 08:05AM	Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-12-23 10:51AM	Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 10:25AM	Q3 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) +10.90%
Nov-08-23 05:51PM	Akoya Biosciences Inc (AKYA) Reports 34% Year-Over-Year Revenue Growth in Q3 2023 (GuruFocus.com)
04:05PM	Akoya: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance (GlobeNewswire)
Nov-02-23 08:00AM	Akoya to Participate at Three Upcoming Investor Conferences (GlobeNewswire) +7.92%
Nov-01-23 10:01AM	Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-31-23 09:00AM	Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023 (GlobeNewswire)
Oct-17-23 10:22AM	Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures (GlobeNewswire) +5.41%
Oct-11-23 04:05PM	Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023 (GlobeNewswire) -8.21% -6.10%
Sep-19-23 08:00AM	Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms (GlobeNewswire)
Aug-17-23 09:56AM	10 Healthcare Stocks with Insider Buying (Insider Monkey)
Aug-08-23 12:38PM	Q2 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 06:15PM	Akoya Biosciences (AKYA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Akoya: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance (GlobeNewswire)
08:05AM	Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies (GlobeNewswire)
Aug-06-23 10:57AM	Private equity firms account for 49% of Akoya Biosciences, Inc.'s (NASDAQ:AKYA) ownership, while institutions account for 29% (Simply Wall St.)
Jul-26-23 04:05PM	Akoya to Participate at Three Upcoming Investor Conferences (GlobeNewswire)
Jul-21-23 09:21AM	Emergent's (EBS) Cyfendus Anthrax Vaccine Gets FDA Nod (Zacks)
Jul-12-23 09:55AM	Can Akoya (AKYA) Climb 116.14% to Reach the Level Wall Street Analysts Expect? (Zacks)
08:05AM	Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023 (GlobeNewswire)
Jul-10-23 10:08AM	The past year for Akoya Biosciences (NASDAQ:AKYA) investors has not been profitable (Simply Wall St.) +5.47%
Jun-13-23 07:58PM	Insiders Pour Millions Into These 2 Stocks, J.P. Morgan Says They Have up to 175% Upside Heres Why You Should Pay Attention (TipRanks) +20.40% +16.79%
12:32PM	Why Shares of Akoya Biosciences Jumped on Tuesday (Motley Fool)
08:29AM	Independent Director of Akoya Biosciences Picks Up 26% More Stock \ (Simply Wall St.)
06:37AM	Daily Vickers Top Buyers & Sellers for 06/13/2023 (Argus Research)
Jun-12-23 04:05PM	Akoya to Participate at Two Upcoming Investor Conferences (GlobeNewswire)
Jun-08-23 12:55AM	Akoya Biosciences Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -5.04%
Jun-07-23 04:08PM	Akoya Biosciences Announces Public Offering of Common Stock (GlobeNewswire)
May-09-23 10:43AM	Q1 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-08-23 05:35PM	Akoya Biosciences (AKYA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -5.99%
04:32PM	Akoya: Q1 Earnings Snapshot (AP Finance)
04:05PM	Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance (GlobeNewswire)
May-05-23 07:36AM	Is Akoya Biosciences, Inc. (NASDAQ:AKYA) Trading At A 34% Discount? (Simply Wall St.)
Apr-27-23 08:00AM	Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument (GlobeNewswire)
Apr-17-23 12:20PM	A Piece Of The Puzzle Missing From Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Share Price (Simply Wall St.) +6.53%
Apr-14-23 03:38PM	Down More Than 50%: These 2 Strong Buy Stocks Are Flirting With a Bottom (TipRanks)
Apr-12-23 08:00AM	Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow (GlobeNewswire) -6.48%
08:00AM	Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data (GlobeNewswire)
Apr-06-23 08:00AM	Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023 (GlobeNewswire)
Mar-20-23 04:00PM	Akoya Biosciences Announces Leadership Transition (GlobeNewswire) -5.47% +8.68%
Mar-09-23 05:17AM	Akoya Biosciences Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Mar-08-23 07:21AM	Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 09:52AM	Q4 2022 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-06-23 05:35PM	Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -5.11%
04:05PM	Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance (GlobeNewswire)
Feb-28-23 08:00AM	Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel (GlobeNewswire) -5.41%
Feb-27-23 10:00AM	Will Akoya Biosciences (AKYA) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-10-23 06:36PM	Argo Group and Akoya Biosciences Stock See Action From Activist Investors (Barrons.com)
Feb-06-23 08:05AM	Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences (GlobeNewswire)
Feb-01-23 08:00AM	Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting (GlobeNewswire)
Jan-08-23 04:00PM	Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022 (GlobeNewswire)
Jan-06-23 08:00AM	Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications (Business Wire) +9.48%
Dec-28-22 04:00PM	Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +10.47%
Dec-15-22 04:00PM	Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day (GlobeNewswire)
Dec-07-22 05:15AM	Institutions own 23% of Akoya Biosciences, Inc. (NASDAQ:AKYA) shares but private equity firms control 49% of the company (Simply Wall St.)
Nov-07-22 05:25PM	Akoya Biosciences (AKYA) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -5.86% -9.76%

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McKelligon Brian	President and CEO	Jun 11 '24	Option Exercise	0.30	7,500	2,272	232,233	Jun 12 04:01 PM
McKelligon Brian	President and CEO	Jun 11 '24	Sale	2.08	7,500	15,630	224,733	Jun 12 04:01 PM
McKelligon Brian	President and CEO	Jun 06 '24	Option Exercise	0.30	7,500	2,272	232,233	Jun 07 09:56 PM
McKelligon Brian	President and CEO	Jun 06 '24	Sale	2.01	7,500	15,064	224,733	Jun 07 09:56 PM
McKelligon Brian	President and CEO	Mar 20 '24	Option Exercise	0.30	7,500	2,272	239,368	Mar 22 05:54 PM
McKelligon Brian	President and CEO	Mar 20 '24	Sale	4.97	7,500	37,243	231,868	Mar 22 05:54 PM
McKelligon Brian	President and CEO	Mar 13 '24	Sale	4.94	7,500	37,035	224,368	Mar 14 08:41 PM
McKelligon Brian	President and CEO	Dec 19 '23	Option Exercise	0.30	7,500	2,272	160,063	Dec 20 07:16 PM
McKelligon Brian	President and CEO	Dec 19 '23	Sale	4.48	7,500	33,566	152,563	Dec 20 07:16 PM
McKelligon Brian	President and CEO	Dec 12 '23	Option Exercise	0.30	7,500	2,272	160,063	Dec 14 04:24 PM
McKelligon Brian	President and CEO	Dec 12 '23	Sale	4.25	7,500	31,871	152,563	Dec 14 04:24 PM
McKelligon Brian	President and CEO	Nov 20 '23	Option Exercise	0.30	7,500	2,272	160,063	Nov 22 04:00 PM
McKelligon Brian	President and CEO	Nov 20 '23	Sale	4.39	7,500	32,901	152,563	Nov 22 04:00 PM

Open in Screener

QSI

Quantum-Si Incorporated

Nov 12 • 04:00PM ET

0.7753

Dollar change -0.2242
Percentage change -22.43	%

Healthcare • Medical Devices • USA • NASD

QSI Quantum-Si Incorporated daily Stock Chart

Peers: ILMN NTRA GH TXG PACB EXAS BDX TWST QGEN NVCR

| Held by: ARKG VTI IWM VXF IWN VTWO IWC VTWV RSSL IWV

Index	RUT	P/E	-	EPS (ttm)	-0.63	Insider Own	31.75%	Shs Outstand	121.83M	Perf Week	-8.56%
Market Cap	110.37M	Forward P/E	-	EPS next Y	-0.81	Insider Trans	0.57%	Shs Float	97.16M	Perf Month	-4.30%
Income	-89.35M	PEG	-	EPS next Q	-0.20	Inst Own	36.18%	Short Float	6.07%	Perf Quarter	-11.96%
Sales	1.70M	P/S	64.93	EPS this Y	2.21%	Inst Trans	0.64%	Short Ratio	11.97	Perf Half Y	-57.63%
Book/sh	1.64	P/B	0.47	EPS next Y	-22.56%	ROA	-29.89%	Short Interest	5.90M	Perf Year	-45.40%
Cash/sh	1.53	P/C	0.51	EPS next 5Y	-	ROE	-32.58%	52W Range	0.70 - 2.43	Perf YTD	-61.43%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-38.30%	52W High	-68.09%	Beta	3.06
Dividend TTM	-	Quick Ratio	20.13	Sales past 5Y	0.00%	Gross Margin	-223.38%	52W Low	10.76%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	20.57	EPS Y/Y TTM	22.49%	Oper. Margin	-5999.65%	RSI (14)	44.87	Volatility	9.56% 7.84%
Employees	165	Debt/Eq	0.01	Sales Y/Y TTM	270.81%	Profit Margin	-5249.65%	Recom	2.00	Target Price	2.50
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	9.96%	Payout	-	Rel Volume	2.99	Prev Close	1.00
Sales Surprise	-25.72%	EPS Surprise	7.69%	Sales Q/Q	203.41%	Earnings	Nov 12 BMO	Avg Volume	493.15K	Price	0.78
SMA20	-4.29%	SMA50	-10.01%	SMA200	-40.60%	Trades		Volume	1,475,505	Change	-22.43%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-23	Initiated	H.C. Wainwright	Buy	$3
Sep-25-23	Downgrade	Canaccord Genuity	Buy → Hold	$3.50 → $2
Oct-20-21	Initiated	Canaccord Genuity	Buy	$13

Nov-12-24 07:30AM	Quantum-Si Reports Third Quarter 2024 Financial Results (Business Wire) -22.43%
Nov-07-24 04:01PM	University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Sis Next-Gen Protein Sequencer Platinum (Business Wire)
Nov-05-24 09:00AM	Quantum-Si to Participate in Upcoming Investment Conferences (Business Wire) +11.92%
Oct-31-24 03:35PM	Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 (Business Wire) -5.27%
Oct-30-24 06:00AM	Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting (Business Wire)
06:00AM	Loading…
Oct-23-24 06:00AM	Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 (Business Wire)
Oct-17-24 05:21PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-10-24 06:00AM	Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024 (Business Wire)
Sep-24-24 06:00AM	Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing (Business Wire)
Sep-19-24 06:00AM	Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 (Business Wire) +6.00%
Sep-04-24 06:00AM	Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing Platform to Enhance Gene Therapy Development (Business Wire)
Aug-27-24 06:01PM	CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Business Wire)
04:30PM	Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Business Wire)
Aug-26-24 06:00AM	Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire) -5.94%
Aug-07-24 04:02PM	Quantum-Si Reports Second Quarter 2024 Financial Results (Business Wire) -5.91%
04:05PM	Loading…
Jul-30-24 04:05PM	Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-17-24 04:05PM	Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire) -6.03%
Jul-09-24 03:56PM	3 Super-Cheap Penny Stocks for the Ultimate Speculator (InvestorPlace)
Jun-10-24 09:00AM	Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata (Business Wire)
May-31-24 08:00AM	Quantum-Si Announces Presentations at ASMS and ESHG (Business Wire)
May-30-24 04:05PM	Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors (Business Wire)
May-09-24 04:01PM	Quantum-Si Reports First Quarter 2024 Financial Results (Business Wire) -7.10%
Apr-30-24 08:30AM	Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time (Business Wire)
Apr-18-24 04:05PM	Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
Mar-21-24 04:05PM	Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors (Business Wire) -5.79%
Mar-07-24 12:01PM	Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing on Platinum at US HUPO Conference (Business Wire) +29.81%
Feb-29-24 04:05PM	Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire) +10.78%
Feb-27-24 08:30AM	Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar (Business Wire) +5.36%
Feb-09-24 08:00AM	Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 (Business Wire) +6.94%
Feb-05-24 08:00AM	Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing Platform (Business Wire)
08:30AM	Loading…
Jan-18-24 08:30AM	Quantum-Si Introduces Worlds First Next-Generation Protein Sequencer in Japan with Addition of New Distributor (Business Wire)
Dec-12-23 08:30AM	Quantum-Si Expands Global Reach with Addition of New Distributor (Business Wire)
Nov-15-23 08:30AM	Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum Grows (Business Wire)
Nov-11-23 09:18AM	Quantum-Si incorporated (NASDAQ:QSI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:05PM	Quantum-Si Reports Third Quarter 2023 Financial Results (Business Wire) +7.26% +6.77%
Nov-08-23 08:15AM	Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards (Business Wire) -6.06%
Nov-01-23 08:30AM	Quantum-Si to Participate at Two Upcoming Investor Conferences (Business Wire)
Oct-31-23 08:00AM	Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023 (Business Wire)
Oct-17-23 08:30AM	Quantum-Si to Report Third Quarter 2023 Financial Results on November 9, 2023 (Business Wire)
Oct-05-23 06:36PM	CORRECTING AND REPLACING Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization (Business Wire)
08:00AM	Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization (Business Wire)
Oct-03-23 08:00AM	Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts (Business Wire)
Sep-21-23 08:00AM	Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors (Business Wire)
Aug-22-23 07:05AM	Quantum-Sis Platinum Next-Generation Protein Sequencing Instrument Wins Honorable Mention in Fast Companys 2023 Innovation by Design Awards (Business Wire)
Aug-16-23 04:00PM	Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-14-23 06:02PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -9.73%
Aug-07-23 08:00AM	Quantum-Si Reports Second Quarter 2023 Financial Results (Business Wire) -32.15%
Jul-26-23 08:00AM	Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference (Business Wire)
Jul-18-23 04:00PM	Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023 (Business Wire) +9.57%
Jun-21-23 08:00AM	Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations (Business Wire)
Jun-07-23 08:00AM	Quantum-Si Debuts New Headquarters in Branford, Connecticut (Business Wire)
May-25-23 08:00AM	Quantum-Si to Participate in the Jefferies Healthcare Conference (Business Wire) -5.99%
May-22-23 08:00AM	Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors (Business Wire) +15.13%
May-15-23 08:00AM	Scott Mendel Elected to Quantum-Si Board of Directors (Business Wire)
May-11-23 04:00PM	Quantum-Si Reports First Quarter 2023 Financial Results (Business Wire) -5.52% -8.44%
May-02-23 08:00AM	Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer (Business Wire)
Apr-24-23 08:00AM	Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments (Business Wire)
Apr-20-23 08:00AM	Quantum-Si to Report First Quarter 2023 Financial Results on May 11, 2023 (Business Wire)
Apr-14-23 08:00AM	Quantum-Si To Present Poster on Single-Molecule Method for Detection of Arginine Post-Translational Modifications at the AACR Annual Meeting 2023 (Business Wire)
Mar-24-23 08:00AM	Quantum-Si to Participate in B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference (Business Wire)
Mar-06-23 08:00AM	Quantum-Si Reports Fourth Quarter and Fiscal Year 2022 Financial Results (Business Wire) -12.96%
Feb-17-23 08:00AM	Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference (Business Wire)
Feb-13-23 04:00PM	Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (Business Wire)
Jan-09-23 08:00AM	Quantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire) +8.72%
08:00AM	Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum Next-Generation Protein Sequence Platform Output (Business Wire)
08:00AM	Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing (Business Wire)
Dec-22-22 04:05PM	Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-22 08:00AM	Quantum-Si Announces Commercial Availability of PlatinumTM, the Worlds First Next-Generation Single-Molecule Protein Sequencing Platform (Business Wire)
Dec-08-22 08:00AM	Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board (Business Wire)
Nov-07-22 04:05PM	Quantum-Si Reports Third Quarter 2022 Financial Results (Business Wire)
Nov-03-22 04:00PM	Quantum-Si to Participate in the 16th Annual Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) -11.15%
Oct-17-22 04:05PM	Quantum-Si to Report Third Quarter 2022 Financial Results on November 7, 2022 (Business Wire) +6.11%
Oct-13-22 02:00PM	Quantum-Sis Next-Generation Single-Molecule Protein Sequencing Technology Published in Science, Signaling New Era of Life Science and Biomedical Research (Business Wire)
Oct-04-22 08:00AM	Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer (Business Wire) +18.48%
Aug-26-22 08:00AM	Quantum-Si to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (Business Wire) -6.40%
Aug-08-22 04:02PM	Quantum-Si Reports Second Quarter 2022 Financial Results (Business Wire) -9.34%
Jul-29-22 08:30AM	Quantum-Si to Participate at Two Upcoming Investor Conferences (Business Wire)
Jul-18-22 04:42PM	Quantum-Si to Report Second Quarter 2022 Financial Results on August 8, 2022 (Business Wire) +7.91%
Jun-22-22 08:45AM	Quantum-Si Set to Join the Russell 2000® Index (Business Wire) +6.83%
Jun-16-22 04:30PM	Quantum-Si Appoints Vikram Bajaj, Ph.D., to Board of Directors (Business Wire) -10.71%
Jun-01-22 08:45AM	Quantum-Si Highlights Technology Advancements at the VIB Next-Generation Protein Analysis and Detection Conference (Business Wire)
May-25-22 08:00AM	Quantum-Si to Present at the 2022 Jefferies Healthcare Conference (Business Wire)
May-17-22 11:00AM	Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference (Business Wire) +8.09%
May-10-22 08:00AM	Quantum-Si to Present at the 2022 UBS Global Healthcare Conference (Business Wire)
May-09-22 04:05PM	Quantum-Si Reports First Quarter 2022 Financial Results (Business Wire) -11.87%
04:01PM	Quantum-Si Appoints Patrick Schneider as President and Chief Operating Officer (Business Wire)
Apr-18-22 04:13PM	Quantum-Si to Report First Quarter 2022 Financial Results on May 9, 2022 (Business Wire)
Mar-28-22 04:05PM	Quantum-Si to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Virtual Mini Conference (Business Wire) +13.91%
Mar-14-22 12:39PM	What You Need To Know About Quantum-Si incorporated's (NASDAQ:QSI) Investor Composition (Simply Wall St.) -5.85%
Feb-28-22 04:05PM	Quantum-Si Reports Fourth Quarter and Fiscal Year 2021 Financial Results (Business Wire) -5.88% +13.46%
Feb-18-22 09:21AM	Quantum-Si to Present at the 42nd Annual Cowen Health Care Conference (Business Wire) +11.65%
Feb-14-22 04:05PM	Quantum-Si Announces Dr. Jonathan Rothberg as Interim CEO (Business Wire) -6.24%
Feb-07-22 04:05PM	Quantum-Si to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022 (Business Wire)
Jan-10-22 04:10PM	Quantum-Si Provides Business Updates at the 40th Annual J.P. Morgan Healthcare Conference (Business Wire) -9.15% +7.51%
Jan-04-22 08:00AM	Quantum-Si Signs Lease for New Headquarters in New Haven (Business Wire) -6.57%
Dec-21-21 08:00AM	Quantum-Si to Present at the 40th Annual J.P. Morgan Healthcare Conference (Business Wire) +22.91%
Dec-14-21 09:25AM	Quantum-Si Added to the Nasdaq Biotechnology Index (Business Wire)
Dec-02-21 10:15AM	3D Systems Names Claudia Napal Drayton to Board of Directors (GlobeNewswire)
Nov-10-21 04:05PM	Quantum-Si Reports Third Quarter 2021 Financial Results (Business Wire)
Nov-09-21 08:00AM	Quantum-Si Acquires Majelac Technologies to Strengthen Chip Supply Chain (Business Wire)

Quantum-Si, Inc. engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion. It can be used for the study of nucleic acids. Its platform includes Carbon automated sample preparation instrument, Platinum NGPS instrument, Quantum-Si Cloud software service, and reagent kits and chips for use with its instruments. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vieceli John S.	Chief Product Officer	Sep 23 '24	Sale	0.95	2,192	2,073	166,916	Sep 25 04:24 PM
Vieceli John S.	Chief Product Officer	Sep 24 '24	Sale	0.93	2,117	1,970	164,799	Sep 25 04:24 PM
Hawkins Jeffrey Alan	President & CEO	Aug 09 '24	Buy	0.85	25,000	21,272	1,003,757	Aug 13 06:01 AM
LaPointe Christian	General Counsel & Corp. Secr.	Aug 09 '24	Buy	0.86	25,000	21,610	571,710	Aug 13 06:01 AM
Keyes Jeffry R.	Chief Financial Officer	Aug 09 '24	Buy	0.87	50,000	43,465	446,820	Aug 13 06:01 AM
Kummeth Charles R.	Director	Aug 09 '24	Buy	0.87	138,900	120,926	323,900	Aug 13 06:01 AM
Kummeth Charles R.	Director	Aug 12 '24	Buy	0.89	31,100	27,533	355,000	Aug 13 06:01 AM
Johnston Grace	Chief Commercial Officer	Jun 21 '24	Sale	1.21	4,359	5,262	299,109	Jun 25 07:18 PM
Johnston Grace	Chief Commercial Officer	Jun 24 '24	Sale	1.20	3,169	3,790	295,940	Jun 25 07:18 PM
Hawkins Jeffrey Alan	President & CEO	Mar 14 '24	Buy	1.76	25,000	44,000	25,000	Mar 18 08:21 AM
LaPointe Christian	General Counsel & Corp. Secr.	Mar 15 '24	Buy	1.74	10,000	17,400	257,693	Mar 18 08:07 AM
Keyes Jeffry R.	Chief Financial Officer	Mar 05 '24	Buy	1.61	50,000	80,500	50,000	Mar 06 05:09 PM

AKYA

Akoya Biosciences Inc

QSI

Quantum-Si Incorporated

Upgrade your FINVIZ experience